Open Access Green as soon as Postprint is submitted to ZB.
Melanoma patients respond to a new HLA-1*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2.
Int. J. Cancer 116, 944-948 (2005)
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
melanoma; tumor antigen; TRP-2; T cell epitope; immunotherapy
ISSN (print) / ISBN
0020-7136
e-ISSN
1097-0215
Journal
International Journal of Cancer
Quellenangaben
Volume: 116,
Pages: 944-948
Publisher
Wiley
Reviewing status
Peer reviewed
Institute(s)
Institute of Virology (VIRO)